Abvc Biopharma (ABVC) Income from Non-Controlling Interests (2021 - 2026)
Abvc Biopharma (ABVC) reported Income from Non-Controlling Interests of -$73,547 for Q2 2026, compared with -$75,811 a year earlier.
Powered by 
Analysis
Abvc Biopharma (ABVC) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Abvc Biopharma's Income from Non-Controlling Interests came in at -$493,721; for FY2025, it was -$468,405.
- By year, Income from Non-Controlling Interests came in at -$356,159 in FY2024, -$492,794 in FY2023, $110,865 in FY2022 (-86.2%) and $802,962 in FY2021.
- Five-year quarterly Income from Non-Controlling Interests spans a low of -$316,981 in Q4 2023 and a high of $1.03 million in Q4 2021.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$129,695 (Q1 2026), -$249,469 (Q4 2025) and -$41,010 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Abvc Biopharma | 26.03 Mn | 28.01 Mn | - | -73,547.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -73,547.00 |
| Mar 31, 2026 | -129,695.00 |
| Dec 31, 2025 | -249,469.00 |
| Sep 30, 2025 | -41,010.00 |
| Jun 30, 2025 | -75,811.00 |
| Mar 31, 2025 | -102,115.00 |
| Dec 31, 2024 | -64,953.00 |
| Sep 30, 2024 | -92,662.00 |
| Jun 30, 2024 | -105,076.00 |
| Mar 31, 2024 | -93,468.00 |
| Dec 31, 2023 | -316,981.00 |
| Sep 30, 2023 | -50,564.00 |
| Jun 30, 2023 | -51,714.00 |
| Mar 31, 2023 | -73,535.00 |
| Dec 31, 2022 | 363,036.00 |
| Sep 30, 2022 | -71,660.00 |
| Jun 30, 2022 | -88,336.00 |
| Mar 31, 2022 | -92,175.00 |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | -79,756.00 |
API Access
Abvc Biopharma Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();